Intravitreal bevacizumab in advanced-stage neovascular age-related macular degeneration with visual acuity lower than 20/200

Archives of Ophthalmology

Volumn 130, Issue 7, 2012, Pages 934-935

  Parodi, Maurizio Battaglia ^a   Cascavilla, Marialucia ^a   Papayannis, Alexandros ^b   Kontadakis, Dimitrios Stelios ^a   Bandello, Francesco ^a   Iacono, Pierluigi ^a,c  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b Ospedale Conegliano Veneto   (Italy)

^c IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUORESCEIN;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; HUMAN; INSTITUTIONAL REVIEW; LOADING DRUG DOSE; MALE; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; STUDENT T TEST; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTRAVITREAL INJECTIONS; MALE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISION DISORDERS; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84863806227     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.2617     Document Type: Article

References (4)

1. Chakravarthy U, Adamis AP, Cunningham ET Jr, et al VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology. 2006;113(9): 1508.e1-1508.e25.
2. Brown DM, Kaiser PK, Michels M, et al ANCHOR Study Group. Ranibizumab vs verteporfin for neovascular age-related macular degeneration.NEngl J Med. 2006;355(14):1432-1444. (Pubitemid 44511558)
3. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T; ANCHOR Study Group. Ranibizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology. 2009;116(1):57-65, e5.
4. Rosenfeld PJ, Brown DM, Heier JS, et al MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl JMed. 2006; 355(14):1419-1431. (Pubitemid 44511557)